Divi's Laboratories Ltd. - Research Center
532488 DIVISLAB Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 7,665.00 | 7,625.30 | 8,879.82 | 6,798.61 | 5,310.57 |
| Operating profit | 2,174.00 | 2,347.68 | 3,876.46 | 2,820.68 | 1,815.44 |
| Interest | 3.00 | 0.52 | 0.65 | 0.69 | 6.06 |
| Gross profit | 2,508.00 | 2,696.17 | 3,987.07 | 2,882.52 | 1,999.24 |
| EPS (Rs) | 59.47 | 68.12 | 111.08 | 73.64 | 51.71 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 337.00 | 349.01 | 111.26 | 62.53 | 189.86 |
| Stock adjustment | -127.00 | 50.16 | -449.99 | -100.00 | -94.10 |
| Raw material | 3,210.00 | 2,979.49 | 3,439.79 | 2,365.50 | 2,182.66 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1,067.00 | 953.05 | 926.55 | 808.68 | 608.36 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,341.00 | 1,294.92 | 1,087.01 | 903.75 | 798.21 |
| Provisions made | - | - | - | - | - |
| Depreciation | 376.00 | 342.07 | 310.55 | 254.65 | 185.95 |
| Taxation | 556.00 | 545.95 | 727.98 | 673.15 | 440.58 |
| Net profit / loss | 1,576.00 | 1,808.15 | 2,948.54 | 1,954.72 | 1,372.71 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 53.00 | 53.09 | 53.09 | 53.09 | 53.09 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 28.36 | 30.79 | 43.65 | 41.49 | 34.19 |
| GPM (%) | 31.34 | 33.81 | 44.34 | 42.01 | 36.35 |
| NPM (%) | 19.70 | 22.67 | 32.79 | 28.49 | 24.96 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis